Improvements in Renal Function with Selinexor in Relapsed/Refractory Multiple Myeloma: Post-hoc Analyses from the STORM Study
Year: 2019
Type: article
Authors: Dan T. Vogl, Ajay Nooka, Maria Gavriatopoulou, Andrew Yee, Carol Huff, Philippe Moreau, David Dingli, Craig Cole, Paul G. Richardson, Meletios A. Dimopoulos, Sagar Lonial, Keith Stewart, Ajai Chari, Joshua Richter, Noa Biran, David S. Siegel, Jianjun Liu, Anita Joshi, Jatin Shah, Sharon Shacham, Michael Kauffman, Sundar Jagannath
Institutions: Abramson Cancer Center, University of Pennsylvania, Winship Cancer Institute, National and Kapodistrian University of Athens, Massachusetts General Hospital, Johns Hopkins University, Centre Hospitalier Universitaire de Nantes, Nantes Université, U-M Rogel Cancer Center, Harvard University, Dana-Farber Cancer Institute, Alexandra Hospital, Emory University, Mayo Clinic, Mayo Clinic in Arizona, Icahn School of Medicine at Mount Sinai, Hackensack University Medical Center, Karyopharm Therapeutics (United States), Mount Sinai Hospital
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2980531550